ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Keytruda Granted Approval In Metastatic Melanoma

September 26, 2014

New Cancer Education Grant Program Guidelines, Developed

February 6, 1987

In Brief: EORTC-NCI Exchange Program Invites U.S. applicants; USC Seeks Eye Melanoma Patients

December 5, 1986

In Brief: John Campbell, Nida Contracts Chief, New Head Of NCI Contracts Branch; PHS Honors Seven At NCI

June 10, 1983

NCI Getting a Lot For a Little Money It Spends Overseas, International Program Director Says

June 17, 1977

Simone Replaces Levine As Cancer Policy Board Chairman

April 19, 2002